Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Interferon Cytokine Res ; 28(7): 435-44, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18597621

RESUMO

Increasing resistance to anthelmintic drugs indicates a vital need to develop alternative strategies to control helminth infections. Interleukin-3 (IL-3) is a multilineage hematopoietic growth regulator produced by activated T lymphocytes in response to infection. In helminth infections, eosinophils play an important role in the elimination of parasites through their recruitment of inflammatory cells and the release of granules. The ability of IL-3 to stimulate the development of eosinophils makes it a particularly important candidate for therapeutic use to protect against parasites. To enable the role of IL-3 in the development, growth, and differentiation of porcine eosinophils to be elucidated, recombinant IL-3 (rPoIL-3) was expressed and purified. As the amino acid sequence identities between porcine IL-3 and other reported species were quite low ( approximately 39% between human and pig), an assessment of the in vitro activity of rPoIL-3 was made. The culture of porcine bone marrow (BM) cells with rPoIL-3 stimulated the proliferation of SWC3a(hi) myeloid cells, conA rming that rPoIL-3 acted as a hematopoietic cell growth factor. Since rPoIL-3 stimulated the development of myeloid cells in culture, the in vivo potential to produce elevated eosinophil proportions was assessed. In vivo administration of rPoIL-3 induced a signiA cant increase in the number of eosinophils in blood. These results suggest that rPoIL-3 is a potent inducer of eosinophils in swine and supports the inclusion of rPoIL-3 in therapeutic strategies.


Assuntos
Células da Medula Óssea/efeitos dos fármacos , Eosinófilos/citologia , Interleucina-3/administração & dosagem , Proteínas Recombinantes/administração & dosagem , Animais , Células da Medula Óssea/citologia , Células da Medula Óssea/imunologia , Bovinos , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Eosinófilos/efeitos dos fármacos , Eosinófilos/imunologia , Humanos , Interleucina-3/imunologia , Contagem de Leucócitos , Camundongos , Modelos Biológicos , Conformação Molecular , Doenças Parasitárias/sangue , Doenças Parasitárias/tratamento farmacológico , Proteínas Recombinantes/imunologia , Análise de Sequência de Proteína , Ovinos , Suínos
2.
Vaccine ; 21(21-22): 2900-5, 2003 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-12798633

RESUMO

DNA vaccines have great potential but despite the promise shown in rodent models, responses in large animals, including humans, have been disappointing. Furthermore, gene gun delivery of DNA has been used to improve these responses. However, most cells that are transfected are not the professional antigen presenting cells (APC) which are critical for generating the primary immune response. Here, we show that in the large animal model of the pig, the combination of the use of gene gun delivery and a DNA vector that targets antigen presenting cells by expressing a CTLA4-ovalbumin (OVA) fusion antigen, leads to enhanced ovalbumin specific serum IgG, IgA, IgG1 and IgG2 immune responses.


Assuntos
Antígenos de Diferenciação/genética , Antígeno B7-1/imunologia , Biolística , Ovalbumina/genética , Proteínas Recombinantes de Fusão/imunologia , Vacinas de DNA/administração & dosagem , Animais , Antígenos CD , Antígenos de Diferenciação/biossíntese , Antígenos de Diferenciação/imunologia , Células COS , Antígeno CTLA-4 , Chlorocebus aethiops , Citomegalovirus/genética , Ensaio de Imunoadsorção Enzimática , Vetores Genéticos , Imunoglobulina A/sangue , Imunoglobulina G/sangue , Modelos Biológicos , Ovalbumina/biossíntese , Ovalbumina/imunologia , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/genética , Suínos , Fatores de Tempo , Transfecção , Vacinas de DNA/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA